Clearmind Medicine (CMND) Return on Capital Employed [ROCE] (2023 - 2026)
Clearmind Medicine's Return on Capital Employed [ROCE] came in at -73.17% for fiscal Q2 2026 (quarter ended Apr 30, 2026), up 58.40 percentage points from -131.57% a year earlier.
Powered by 
Analysis
Clearmind Medicine (CMND) Return on Capital Employed [ROCE] (2023 - 2026) Analysis & Trends
For FY2024 (ended Oct 31, 2024), Clearmind Medicine's Return on Capital Employed [ROCE] was -162.10%.
- Going back by fiscal year, Return on Capital Employed [ROCE] was -1246.59% in FY2022.
- The fiscal Q2 2026 figure represents the highest quarterly Return on Capital Employed [ROCE] in data going back to fiscal Q1 2023.
- Year-over-year, Return on Capital Employed [ROCE] increased in five of the last six quarters, with an average year-over-year change of +652.63 percentage points.
- The fastest year-over-year change in Return on Capital Employed [ROCE] over five years came in fiscal Q4 2024 (a gain of 3675.25 percentage points), and the weakest in fiscal Q3 2024 (a drop of 147.62 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 46.74% |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 17.83% |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 17.92% |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 6.28% |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 19.32% |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 9.54% |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 16.66% |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | -5.97% |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 11.86% |
| 10 | Clearmind Medicine | 9,150.48 | 9,150.48 | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2026 | -73.17% |
| Jul 31, 2025 | -151.01% |
| Apr 30, 2025 | -131.57% |
| Jan 31, 2025 | -113.53% |
| Oct 31, 2024 | -117.95% |
| Jul 31, 2024 | -277.53% |
| Apr 30, 2024 | -153.12% |
| Jan 31, 2024 | -295.24% |
| Oct 31, 2023 | -3,793.20% |
| Jul 31, 2023 | -129.91% |
| Apr 30, 2023 | -229.46% |
| Jan 31, 2023 | -336.04% |
API Access
Clearmind Medicine Return on Capital Employed [ROCE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=CMND&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-capital-employed-[roce]", "ticker": "CMND", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=CMND&period=max&api_key=YOUR_API_KEY");
const data = await res.json();